15 Frequently Asked Questions : Bone Marrow Transplant Treatment in India for Omani Patients

Q1 · What is Bone Marrow Transplant Treatment?

Bone Marrow Transplant is a treatment in which healthy blood-forming stem cells are infused into a patient's bloodstream after appropriate preparation.

These stem cells can develop into

• Red blood cells
• White blood cells
• Platelets
• Other blood-forming cells

A transplant may be recommended when the patient's bone marrow is unable to produce healthy blood cells or when intensive treatment is required to control an underlying disease.

Bone Marrow Transplant may be used for selected patients with

• Acute myeloid leukaemia
• Acute lymphoblastic leukaemia
• Certain lymphomas
• Multiple myeloma
• Myelodysplastic syndromes
• Aplastic anaemia
• Certain inherited blood disorders
• Selected immune-system disorders
• Certain metabolic or genetic disorders
• Other serious bone marrow disorders

There are two major transplant categories.

Autologous Transplant

The patient's own stem cells are collected, stored and later returned after conditioning treatment.

Allogeneic Transplant

Stem cells are obtained from another person who is sufficiently compatible with the patient.

The donor may be

• A matched sibling
• Another matched family member
• A matched unrelated donor
• A haploidentical family donor
• Another suitable donor identified through an appropriate donor search

The transplant type depends on the patient's disease, age, general health, previous treatment, disease status and donor availability.

Q2 · How much does Bone Marrow Transplant cost in Oman compared with India?

Bone Marrow Transplant costs can vary considerably because transplant treatment involves conditioning therapy, stem-cell collection, transplantation, prolonged monitoring, medicines, blood products, infection management and follow-up.

For comparison, the indicative exchange rates used in this guide are

• US$1 ≈ OMR 0.385
• US$1 ≈ INR 96

Indicative Cost Comparison

What may affect the final cost?

The total cost may depend on

• Type of transplant
• Underlying disease
• Disease status at transplant
• Donor availability
• HLA matching
• Donor-search requirements
• Stem-cell collection
• Conditioning regimen
• Chemotherapy
• Immunotherapy where applicable
• Anti-infective medicines
• Blood and platelet transfusions
• ICU requirements
• Complications
• Length of hospitalisation
• Graft-versus-host disease treatment
• Follow-up medicines
• Additional investigations

What should the quotation include?

Omani patients should request a written estimate covering, where applicable

• Pre-transplant evaluation
• HLA testing
• Stem-cell collection
• Conditioning treatment
• Transplant procedure
• Hospitalisation
• Specialist fees
• Nursing care
• Routine laboratory testing
• Blood products
• Standard medicines
• Infection monitoring
• Follow-up during the initial transplant period

The quotation should clearly identify exclusions and possible additional expenses. The above figures are indicative and should not be considered a fixed treatment quotation.

Q3 · Which Indian cities can Omani patients consider for Bone Marrow Transplant Treatment?

Omani patients can consider major Indian medical cities with specialised haematology and transplant services.

For a transplant patient, hospital selection should be based specifically on the availability of an appropriate transplant programme, disease-specific expertise and the required level of supportive care.

Q4 · Which hospitals in India can Omani patients consider for Bone Marrow Transplant Treatment?

Omani patients can consider hospitals in India's major medical cities, subject to confirmation that the required transplant programme and disease-specific specialist team are available.

For Bone Marrow Transplant, patients should specifically confirm the hospital's active transplant programme, adult or paediatric capability, transplant type offered and availability of the appropriate transplant team before making travel arrangements.

Q5 · What types of Bone Marrow Transplant Treatment are available?

The main transplant approaches include:

1. Autologous Stem Cell Transplant

The patient's own stem cells are collected before intensive treatment and returned afterwards.

It may be used for selected

• Multiple myeloma
• Lymphomas
• Other diseases where autologous transplantation is appropriate

2. Allogeneic Stem Cell Transplant

Stem cells come from a donor.

It may be considered for selected

• Acute leukaemias
• Myelodysplastic syndromes
• Aplastic anaemia
• Other bone marrow disorders
• Selected inherited diseases

3. Matched Sibling Transplant

A suitably matched brother or sister may be a donor.

4. Matched Unrelated Donor Transplant

A donor outside the immediate family may be identified through an appropriate donor registry.

5. Haploidentical Transplant

A partially matched family donor may be used in selected situations.

6. Paediatric Stem Cell Transplant

Children with selected malignant, inherited or immune-system disorders may require specialised paediatric transplant programmes.

7. Cord Blood Transplant

Cord blood-derived stem cells may be considered in selected patients when an appropriate source is available.

The appropriate transplant type depends on the patient's diagnosis, disease status, donor availability and transplant team's assessment.

Q6 · Who may be suitable for Bone Marrow Transplant Treatment?

BMT may be considered for selected patients with serious diseases affecting blood formation or the immune system.

Potential indications include

• Acute myeloid leukaemia
• Acute lymphoblastic leukaemia
• Selected lymphomas
• Multiple myeloma
• Myelodysplastic syndromes
• Aplastic anaemia
• Certain inherited blood disorders
• Certain immune deficiencies
• Selected genetic or metabolic disorders
• Other serious bone marrow diseases

However, not every patient with these conditions is automatically suitable for transplant.

The transplant team may consider

• Age
• General health
• Underlying disease
• Disease stage
• Response to previous treatment
• Organ function
• Infection status
• Previous chemotherapy
• Previous transplant
• Donor availability
• HLA compatibility
• Performance status
• Potential transplant risks

A comprehensive transplant assessment is essential before treatment.

Q7 · What tests are required before Bone Marrow Transplant Treatment?

Pre-transplant testing is extensive because the patient must be assessed for both transplant suitability and potential risks.

Blood Tests

These may include

• Complete blood count
• Kidney function
• Liver function
• Electrolytes
• Blood glucose
• Coagulation tests
• Blood group
• Viral screening
• Other disease-specific blood tests

HLA Testing

HLA testing is important when an allogeneic transplant is being considered.

Testing may involve

• Patient HLA typing
• Potential donor HLA typing
• Additional donor compatibility testing

Bone Marrow Evaluation

Depending on the disease, the patient may require

• Bone marrow aspiration
• Bone marrow biopsy
• Flow cytometry
• Cytogenetic testing
• Molecular testing
• Minimal residual disease assessment where applicable

Imaging

Depending on the underlying disease

• CT scan
• PET-CT
• MRI
• Ultrasound
• Chest imaging

Organ Assessment

The transplant team may evaluate

• Heart function
• Lung function
• Kidney function
• Liver function

Tests may include

• ECG
• Echocardiography
• Pulmonary function testing
• Other organ-specific investigations

Infection Screening

Testing may be performed for relevant infections before transplantation.

The exact testing programme varies according to the patient's disease and transplant type.

Q8 · What medical records should Omani patients send before travelling?

Omani patients should provide the transplant centre with complete and recent medical information.

Important records may include

• Final diagnosis
• Bone marrow biopsy reports
• Bone marrow aspiration reports
• Flow cytometry reports
• Cytogenetic reports
• Molecular testing
• PET-CT or CT reports
• MRI reports where applicable
• Previous pathology reports
• Previous chemotherapy details
• Previous radiotherapy details
• Previous transplant records
• Blood-test reports
• Infection-screening reports
• HLA reports
• Donor information
• Medication list
• Previous hospital discharge summaries
• Current clinical status

For blood cancers, the complete treatment history is particularly important.

Patients should provide information about

• Previous chemotherapy cycles
• Drugs received
• Treatment response
• Relapse history
• Current disease status
• Previous complications

If the patient has already been evaluated for transplantation, the previous transplant assessment should also be shared.

Q9 · How does Bone Marrow Transplant Treatment work?

The transplant process generally occurs in several stages.

Step 1: Transplant Evaluation

The specialist reviews the diagnosis, disease status, previous treatment and overall health.

Step 2: Donor Assessment

For an allogeneic transplant, potential donors are evaluated for compatibility.

Step 3: Stem Cell Collection

For an autologous transplant, the patient's stem cells are collected and stored.

For an allogeneic transplant, stem cells are collected from the donor using the appropriate method.

Step 4: Conditioning Treatment

The patient receives chemotherapy, with or without other conditioning treatments, to prepare the body for transplantation.

Step 5: Stem Cell Infusion

The stem cells are infused through the patient's bloodstream.

This is generally not a surgical operation in the conventional sense.

Step 6: Engraftment

The transplanted stem cells begin producing new blood cells.

During this period, the patient may require close monitoring and supportive treatment.

Step 7: Infection Prevention and Monitoring

The immune system can be significantly weakened during the transplant period.

The medical team monitors for

• Fever
• Infection
• Bleeding
• Low blood counts
• Organ complications
• Other transplant-related problems

Step 8: Graft-Versus-Host Disease Monitoring

Patients receiving allogeneic transplantation may be monitored for graft-versus-host disease (GVHD).

Step 9: Early Recovery

Blood counts gradually recover and the medical team continues monitoring the patient.

Step 10: Long-Term Follow-Up

Follow-up may continue for months or longer depending on the transplant type and underlying disease.

Q10 · What are the alternatives to Bone Marrow Transplant Treatment?

BMT is not appropriate or necessary for every patient. Depending on the disease, alternatives or other treatment strategies may include:

Chemotherapy

Drug treatment may be used to control or eliminate abnormal blood cells.

Targeted Therapy

Certain diseases may be treated using medicines designed to target specific molecular or cellular abnormalities.

Immunotherapy

Some blood cancers may be treated with specialised immune-based treatments.

CAR-T Cell Therapy

Selected patients with certain blood cancers may be considered for cellular therapy such as CAR-T treatment where clinically appropriate and available.

Radiotherapy

Radiotherapy may be used for selected cancers and specific clinical situations.

Supportive Treatment

Some patients may require

• Blood transfusions
• Platelet transfusions
• Antibiotics
• Antiviral medicines
• Growth factors
• Other supportive care

Disease-Specific Treatment

Some inherited or bone marrow disorders may have disease-specific medicines or other treatment approaches.

The appropriate alternative depends on the diagnosis, disease status, previous treatment and individual patient factors.

Q11 · What should Omani patients ask before accepting a Bone Marrow Transplant quotation?

Before travelling to India, Omani patients should ask

• What is the exact diagnosis?
• Is Bone Marrow Transplant recommended?
• What is the objective of the transplant?
• Is an autologous or allogeneic transplant required?
• Is a donor already available?
• What type of donor is being considered?
• Is HLA testing required?
• What additional donor testing is needed?
• What conditioning regimen is planned?
• How long will conditioning treatment take?
• How will the stem cells be collected?
• What hospitalisation period is expected?
• What transplant-related medicines are included?
• Are specialist fees included?
• Are laboratory investigations included?
• Are blood and platelet transfusions included?
• Are infection-related medicines included?
• Is ICU treatment included if required?
• What complications could increase the cost?
• What is the estimated total treatment cost?
• What is the estimated duration of stay in India?
• How long will close monitoring be required?
• What follow-up is needed after discharge?
• What medicines may need to be continued after returning to Oman?
• How will follow-up be coordinated in Oman?

Patients should request a written quotation and ask the hospital to clearly identify included and excluded services.

Q12 · How long should Omani patients stay in India?

Bone Marrow Transplant generally requires a much longer stay than many routine surgical procedures.

The total duration may depend on

• Type of transplant
• Underlying disease
• Conditioning regimen
• Donor type
• Engraftment
• Infection
• GVHD
• Other complications
• Recovery of blood counts

The patient may need to remain near the transplant centre even after hospital discharge for continued monitoring.

Before Transplant

Time may be required for

• Initial consultation
• Diagnostic testing
• HLA testing
• Donor evaluation
• Pre-transplant assessment
• Treatment planning

During Transplant

The patient may remain hospitalised during conditioning, stem-cell infusion and early recovery.

After Discharge

Frequent outpatient monitoring may continue.

Therefore, Omani patients should not plan their return flight immediately after discharge without discussing the timing with the transplant team. For complex cases, the patient and accompanying family member should be prepared for an extended stay in India.

Q13 · What is recovery like after Bone Marrow Transplant Treatment?

Recovery after BMT is gradual.

During the early period, patients may experience

• Weakness
• Fatigue
• Reduced appetite
• Nausea
• Mouth sores
• Low blood counts
• Increased infection risk
• Bleeding risk
• Weight changes
• Digestive problems

Patients may require

• Antibiotics
• Antiviral medicines
• Antifungal medicines
• Blood transfusions
• Platelet transfusions
• Nutritional support
• Pain management
• Other supportive treatment

For allogeneic transplant patients, the medical team also monitors for GVHD and other immune-related complications. Recovery may continue for months after transplantation.

Patients may need to follow precautions concerning

• Infection exposure
• Food safety
• Personal hygiene
• Crowded places
• Travel
• Physical activity
• Medication adherence

The transplant team will determine when the patient can gradually resume normal activities.

Q14 · How can follow-up be managed after returning to Oman?

Follow-up planning should be discussed before the patient leaves India.

The Indian transplant centre may provide

• Discharge summary
• Transplant report
• Treatment summary
• Laboratory reports
• Bone marrow reports
• Medication list
• Follow-up schedule
• Instructions regarding infection prevention
• Advice regarding vaccination or other long-term care

After returning to Oman, follow-up may involve

• Haematologist
• Oncologist
• Transplant specialist
• Primary physician
• Infectious-disease specialist when required
• Other specialists depending on complications

Patients may require regular

• Blood counts
• Kidney and liver tests
• Disease monitoring
• Bone marrow assessments
• Medication review
• Infection monitoring
• GVHD assessment where applicable

The Omani doctor and Indian transplant team should ideally have access to the same treatment summary and relevant medical records. Patients should retain copies of all transplant documents for future medical consultations.

Q15 · Should an Omani patient travel to India for Bone Marrow Transplant Treatment?

Omani patients considering Bone Marrow Transplant in India should first undergo a detailed transplant evaluation.

Before travelling, patients should compare

• Diagnosis
• Disease status
• Recommended transplant type
• Donor availability
• HLA compatibility
• Transplant centre experience with the specific disease
• Adult or paediatric transplant facilities
• Intensive-care support
• Infection-control facilities
• Estimated treatment cost
• Expected hospitalisation
• Expected stay in India
• Possible complications
• Long-term follow-up arrangements

Because Bone Marrow Transplant is a complex treatment, the decision should be based on the patient's individual medical condition and the recommendation of qualified transplant specialists. Omani patients should ideally have their medical records reviewed by the transplant centre before travelling so that the treatment pathway, additional investigations and expected duration of stay can be discussed in advance.